Cassels; Frederick J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cassels; Frederick J..The latest application filed is for "oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres".

Company Profile

0.11.12

Cassels; Frederick J. - Gaithersburg MD
Cassels; Frederick J. - Laurel MD
Cassels; Frederick J. - Ellicott City MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres App 20100074913 - Boedeker; Edgar C. ; et al.	2010-03-25
Transformed bacteria producing CS6 antigens as vaccines Grant 7,625,571 - Wolf , et al. December 1, 2	2009-12-01
Oral-intestinal vaccines against diseases caused by enteropathic organisms using antigens encapsulated within biodegradable-biocompatible microspheres Grant 7,604,811 - Jarboe , et al. October 20, 2	2009-10-20
Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein Grant 7,566,540 - Cassels , et al. July 28, 2	2009-07-28
Vaccine for transcutaneous immunization Grant 7,527,802 - Glenn , et al. May 5, 2	2009-05-05
Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins Grant 7,404,961 - Cassels , et al. July 29, 2	2008-07-29
Transformed bacteria producing CS6 antigens as vaccines Grant 7,332,172 - Wolf , et al. February 19, 2	2008-02-19
Transformed Bacteria Producing CS6 Antigens as Vaccines App 20080038319 - Wolf; Marcia Kay ; et al.	2008-02-14
Method of making CS6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections Grant 7,217,541 - Cassels , et al. May 15, 2	2007-05-15
Method for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections with bovine red blood cells App 20050158284 - Ryu, Hyoik ; et al.	2005-07-21
Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein App 20050075486 - Cassels, Frederick J. ; et al.	2005-04-07
Method for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections with bovine red blood cells Grant 6,869,602 - Ryu , et al. March 22, 2	2005-03-22
Transformed bacteria producing CS6 antigens as vaccines App 20050025787 - Wolf, Marcia Kay ; et al.	2005-02-03
Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins App 20040229772 - Cassels, Frederick J. ; et al.	2004-11-18
Animal model for enteric pathogens App 20040191170 - Mond, James J. ; et al.	2004-09-30
Mass spectrometry of colonization factors Grant 6,797,485 - Cassels , et al. September 28, 2	2004-09-28
Vaccine for transcutaneous immunization App 20040146534 - Glenn, Gregory M. ; et al.	2004-07-29
Method of making CS6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections App 20040005662 - Cassels, Frederick J. ; et al.	2004-01-08
Method for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections with bovine erythrocyte preparations App 20030157080 - Ryu, Hyoik ; et al.	2003-08-21
Mass spectrometry of colonization factors App 20020106717 - Cassels, Frederick J. ; et al.	2002-08-08
Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins App 20010014668 - Cassels, Frederick J. ; et al.	2001-08-16
Plaque inhibiting oligosaccharide Grant 5,190,746 - Cassels , et al. March 2, 1	1993-03-02
Plaque inhibiting oligosaccharide Grant 5,071,977 - Cassels , et al. December 10, 1	1991-12-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.